tinea pedis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Age: 18-65 years old; 2 Meet the diagnostic criteria; 3 Those who can complete the test as required and sign the informed consent;
Exclusion criteria
Exclusion criteria: 1 Those who have received systemic antifungal drugs in the last 3 months or topical antifungal drugs in the last 2 weeks; 2 Those who have received long-term treatment with corticosteroids and immunosuppressants; 3 Women who are breastfeeding and pregnant; 4 Those who have received radiotherapy, anti-viral, anti-bacterial, anti-helminthic treatment within the last 2 weeks; 5 Those who are unable to accept and complete the survey as required; 6 Those with co-morbid nail fungal disease, co-morbid bacterial infections such as dengue; 7 Those who have significant abnormalities in the examination of various systems such as blood, liver, kidney and heart; those who have combined serious primary diseases such as cardiovascular, cerebrovascular, hepatic, renal, neurological and haematopoietic systems; and those who are suffering from psychiatric diseases, malignant tumours, diabetes mellitus and autoimmune diseases; 8 Patients who are themselves investigators directly involved in the work of this study; 9 Patients who are allergic to therapeutic drugs; 10 Those with negative laboratory tests for fungi.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy index;Mycological examination; | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation of recurrence (including recurrence or reinfection);Mycological efficacy evaluation;Quality of life score;Evaluation of clinical signs and symptoms; | — |
Countries
China
Contacts
Guangdong Provincial Hospital of Traditional Chinese Medicine